15:44 IST
BSE
Other Announcement
Gufic BioSciences Other Announcement
Gufic Biosciences Ltd has submitted its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI regulations.
Gufic BioSciences Ltd
- Share price
- ₹422.55
- Market cap
- ₹4,237 Cr
- Revenue (annual)
- ₹944.0 Cr
- Net profit (annual)
- ₹64.21 Cr
- P/E (TTM)
- 57.7×Sector 47.3×
- Promoter holding
- 72.50%+0.00% QoQ
- FII holding
- 0.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 5Financial Results 4Acquisition 4Other Announcement 3Merger & Restructuring 3Management Change 2Legal & Regulatory 2Board Meeting Outcome 2Board Meeting Date 2Annual General Meeting 2Dividend 1Credit Rating 1Business Update 1Annual Report 1
Time
3 announcements with these filters
16:22 IST
BSE
Other Announcement
Gufic BioSciences Other Announcement
Gufic Biosciences submitted its Annual Secretarial Compliance Report for the financial year 2026. The report confirms overall regulatory compliance with noted historical fine payments.
12:01 IST
NSE
Other Announcement
Gufic BioSciences Other Announcement
Gufic Biosciences Limited submitted its quarterly compliance certificate for the period ended March 31, 2026. Issued by MUFG Intime India, the certificate confirms that securities received for dematerialisation were processed and listed on the stock exchanges. No shareholder requests were received during the quarter.